Boehringer Ingelheim Prescription Medicines -
Effective primary and specialist care worldwide

These medicinal products require prescription either by primary care physicians or by specialists or form an integral part of hospital treatment.
Prescription Medicines, which represents the bulk of our Human Pharmaceuticals
business, accounts for 77 percent of our total net sales and generated EUR 10,096 million in 2011.